Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / IKT - Inhibikase Therapeutics receives Nasdaq compliance

IKT - Inhibikase Therapeutics receives Nasdaq compliance

Inhibikase Therapeutics Inc.

2023-07-18 06:39:52 ET

  • Clinical-stage pharmaceutical company, Inhibikase Therapeutics, ( NASDAQ: IKT ) receives notice from Nasdaq that it has regained full compliance with the minimum bid price requirement of $1.00 per share.
  • Inhibikase is now in compliance with all applicable listing standards.

For further details see:

Inhibikase Therapeutics receives Nasdaq compliance
Stock Information
Company Name: Inhibikase Therapeutics Inc.
Stock Symbol: IKT
Market: NASDAQ
Website: inhibikase.com
Menu
IKT IKT Quote IKT Short IKT News IKT Articles IKT Message Board
Get IKT Alerts

News, Short Squeeze, Breakout and More Instantly...